Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Nigro, A."'
Autor:
Alessandra Di Paola, Maria Maddalena Marrapodi, Elvira Pota, Rosa Colucci Cante, Deeksha Rana, Giulia Giliberti, Giuseppe Di Feo, Shakeel Ahmed, Domenico Roberti, Roberto Nigro, Francesca Rossi, Maura Argenziano
Publikováno v:
Cancers, Vol 16, Iss 4, p 714 (2024)
The advancement of anti-cancer therapies has markedly improved the survival rate of children with cancer, making them long-term childhood cancer survivors (CCS). Nevertheless, these treatments cause a low-grade inflammatory state, determining inflamm
Externí odkaz:
https://doaj.org/article/d88aa4b2180746ae889e827f64d7a00e
Autor:
Pierluigi Russo, Giuseppe Palermo, Roberto Iacovelli, Mauro Ragonese, Chiara Ciccarese, Giuseppe Maioriello, Fabrizio Fantasia, Francesco Pio Bizzarri, Filippo Marino, Koosha Moosavi, Domenico Nigro, Giovanni Battista Filomena, Filippo Gavi, Francesco Rossi, Francesco Pinto, Marco Racioppi, Nazario Foschi
Publikováno v:
Cancers, Vol 16, Iss 3, p 651 (2024)
Inflammation is widely acknowledged as a significant characteristic of cancer, playing a substantial function in both the initiation and advancement of cancers. In this research, we planned to compare pan-immune inflammation markers and other well-kn
Externí odkaz:
https://doaj.org/article/bf9dfb25598e47919e43f873166b50d6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Cristina Peduto, Mariateresa Zanobio, Vincenzo Nigro, Silverio Perrotta, Giulio Piluso, Claudia Santoro
Publikováno v:
Cancers, Vol 15, Iss 4, p 1217 (2023)
Neurofibromatosis type 1 (NF1) is an autosomal dominant condition, with a birth incidence of approximately 1:2000–3000, caused by germline pathogenic variants in NF1, a tumor suppressor gene encoding neurofibromin, a negative regulator of the RAS/M
Externí odkaz:
https://doaj.org/article/533bc4baa605434e9c541fe76dcd2966
Autor:
Stefano Granieri, Christian Cotsoglou, Alessandro Bonomi, Lisa Salvatore, Roberto Filippi, Olga Nigro, Fabio Gelsomino, Ina Valeria Zurlo, Ilaria Depetris, Riccardo Giampieri, Rossana Berardi, Cristina Morelli, Michele De Tursi, Michela Roberto, Elson Gjoni, Alessandro Germini, Nicola de Angelis, Riccardo Memeo, Antonio Facciorusso, Ornella Garrone, Daryl Ramai, Michele Ghidini, Alessandro Parisi
Publikováno v:
Cancers, Vol 14, Iss 22, p 5513 (2022)
Colorectal cancer (CRC) patients frequently develop liver metastases. Different treatment strategies are available according to the timing of appearance, the burden of metastatic disease, and the performance status of the patient. Systemic treatment
Externí odkaz:
https://doaj.org/article/7e15f4be8c82477988aae314ee10d263
Autor:
Michele Pellegrino, Elena Ricci, Rosangela Ceraldi, Alessandra Nigro, Daniela Bonofiglio, Marilena Lanzino, Catia Morelli
Publikováno v:
Cancers, Vol 14, Iss 18, p 4401 (2022)
Cancer is a major health burden worldwide. Although the plethora of molecular targets identified in the last decades and the deriving developed treatments, which significantly improved patients’ outcome, the occurrence of resistance to therapies re
Externí odkaz:
https://doaj.org/article/80d1025e104d4199af6b16883d48ccb4
Autor:
Luca Lo Nigro, Nellina Andriano, Barbara Buldini, Daniela Silvestri, Tiziana Villa, Franco Locatelli, Rosanna Parasole, Elena Barisone, Anna Maria Testi, Andrea Biondi, Maria Grazia Valsecchi, Carmelo Rizzari, Valentino Conter, Giuseppe Basso, Giovanni Cazzaniga
Publikováno v:
Cancers, Vol 14, Iss 10, p 2475 (2022)
Early T-cell precursor (ETP) is an aggressive form of acute lymphoblastic leukemia (ALL), associated with high risk of relapse. This leukemia subtype shows a higher prevalence of mutations, typically associated with acute myeloid leukemia (AML), incl
Externí odkaz:
https://doaj.org/article/4ea63188571d42e7837e593de8754240
Autor:
Lo Nigro, Luca1 (AUTHOR) lucalonigro1968@gmail.com, Andriano, Nellina1 (AUTHOR), Buldini, Barbara2 (AUTHOR) barbara.buldini@unipd.it, Silvestri, Daniela3 (AUTHOR) daniela.silvestri@unimib.it, Villa, Tiziana4 (AUTHOR) t.villa@gmail.com, Locatelli, Franco5 (AUTHOR) f.locatelli@opbg.net, Parasole, Rosanna6 (AUTHOR) r.parasole@santobonopausilipon.it, Barisone, Elena7 (AUTHOR) elena.barisone@unito.it, Testi, Anna Maria8 (AUTHOR) testi@bce.uniroma1.it, Biondi, Andrea4 (AUTHOR) abiondi.unimib@gmail.com, Valsecchi, Maria Grazia3 (AUTHOR) grazia.valsecchi@unimib.it, Rizzari, Carmelo9 (AUTHOR) c.rizzari@asst-monza.it, Conter, Valentino9 (AUTHOR) valentino.conter@gmail.com, Basso, Giuseppe10 (AUTHOR) giuseppe.basso@unipd.it, Cazzaniga, Giovanni4,11 (AUTHOR) gianni.cazzaniga@asst-monza.it
Publikováno v:
Cancers. May2022, Vol. 14 Issue 10, p2475-N.PAG. 9p.
Autor:
María Julia Lamberti, Annunziata Nigro, Vincenzo Casolaro, Natalia Belén Rumie Vittar, Jessica Dal Col
Publikováno v:
Cancers, Vol 13, Iss 11, p 2566 (2021)
Immunogenic cell death (ICD) in cancer is a functionally unique regulated form of stress-mediated cell death that activates both the innate and adaptive immune response against tumor cells. ICD makes dying cancer cells immunogenic by improving both a
Externí odkaz:
https://doaj.org/article/ca965bdb9d8a4f5d8975a14e5a9bb588